Genetic alterations in prostate cancer initiation and progression

Bench Side Story continues with Dr Kelsie Raspin, a dedicated Postdoctoral Research Fellow specialising in Cancer Genetics at Menzies Institute for Medical Research, University of Tasmania, AUSTRALIA

Her primary research focus revolves around bridging a critical knowledge gap in the understanding of genetic alterations implicated in prostate cancer initiation and its progression into metastatic forms.

Driven by an unwavering commitment to equitable access to genomic innovation in clinical cancer care, Kelsie aspires to enhance health outcomes not only for her fellow Tasmanians but also for individuals worldwide.

Kelsie’s research is funded through an RHH Research Foundation grant.

Scroll to top